Health Insurance Stocks Soar After Boost To Medicare Reimbursement Rates

Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government’s reimbursement rates for Medicare Advantage plans in 2026 signaled some relief for a sector burdened with steep medical costs.

Medicare-focused insurer Humana (HUM.N), opens new tab led gains with a 16% jump, while other health insurers including UnitedHealth Group (UNH.N), opens new tab, Centene (CNC.N), opens new tab and CVS Health (CVS.N), opens new tab advanced between 5% and 10%.

The 5.06% average increase, more than double what the government proposed in January, could help profit margins in the sector after a post-COVID surge in demand for medical procedures drove up costs.

The “rich final rate” also signals a supportive posture by U.S. President Donald Trump’s administration towards Medicare Advantage plans, Jefferies analysts David Windley and Steven Couche wrote in a research note.

The magnitude of the increase versus the provisional rates “reinforces a politically-influenced, ‘more art than science’ reality to rates,” they said.

The Republican-controlled U.S. Senate voted last week to confirm Dr. Mehmet Oz, the celebrity physician nominated by Trump, to oversee Medicare and Medicaid.

The rate the U.S. government pays to private health insurers to manage Medicare for people aged 65 and older or with disabilities influences the monthly premiums these companies charge, the plan benefits they offer and, ultimately, their profits.

The Centers for Medicare & Medicaid Services had earlier proposed a 2.2% increase in 2026 payments.

The agency said the rate change mainly accounts for additional data on rising costs for insurers, including payment data through the fourth quarter of 2024.

Health insurance stocks had a rough 2024 due to low government payments, high medical costs and public backlash against the sector after the murder of a UnitedHealth executive.

But more recently, some stocks have performed well despite a market rout triggered by escalating worries over a trade war. Centene and Molina Healthcare (MOH.N), opens new tab notched gains last week, when broader markets plunged after Trump’s tariff announcement.

 

 

Source Link

Recommended Articles

Trump Says He May Veto Extension of Health Care Subsidies

President Donald Trump said Sunday he may veto a bill to extend Obamacare subsidies if Congress sent one to his desk. Trump’s remark to reporters on Air Force Once comes after nine swing-district House Republicans joined Democrats Wednesday in advancing legislation to revive expired Affordable Care Act subsidies for three years. The Senate has yet to vote ...

Read More

Trump’s Plan To Strong-Arm Insurers Into Lower Prices Is Met With Skepticism

There are reasons to be skeptical that voluntary cuts by insurance companies could bring significant, lasting health care savings for Americans.

Read More

AbbVie To Cut Drug Prices, Pledges $100 Billion For Research

AbbVie (ABBV.N), opens new tab said on Monday that it has struck a three-year deal with U.S. President Donald Trump’s administration to reduce drug prices, and has pledged $100 billion over the next decade for research and development in the country. The drugmaker said the investment will include manufacturing and will expand direct-to-patient offerings through TrumpRx for ...

Read More

Dems Make Health Deal Offer With ACA Subsidies

Democrats sent Republicans a proposal over the weekend to renew enhanced Affordable Care Act subsidies for three years, paired with extensions of other expiring health programs, sources said. Why it matters: Sunday’s offer shows there’s increasing bipartisan sentiment to address long-stalled priorities like overhauling pharmacy benefit manager business practices — even if prospects for the ACA subsidies ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square